Horizon Mutual Holdings leads investment in CredibleMind as the platform scales to serve over 30 million lives across 100+ communities and leading health plans.

SAUSALITO, Calif., Oct. 29, 2024 — CredibleMind, Inc., the Mental Wellbeing Company, today announced it secured $7.5 million in Series A funding, led by Horizon Mutual Holdings, a key partner in advancing access to integrated and personalized mental health support for diverse populations. With this funding, CredibleMind will continue its mission to dismantle barriers to effective mental health support and empower individuals to flourish through accessible, personalized mental wellbeing solutions.

Founded in 2018 by leading academics, technologists, clinicians, and mental wellbeing experts, CredibleMind has rapidly expanded to reach over 30 million lives nationwide, with a strong and growing presence among major health plans and over 100 communities across the U.S.

CredibleMind’s unique platform scans, organizes, and AI-personalizes tens of thousands of expert-curated resources across over one hundred mental health topics. It creates a highly tailored digital experience for each person, blending evidence-based self care and validated assessments with health plan programs and care network resources. By creating a simpler experience that addresses diverse needs, it engages members, reduces access barriers, and delivers expert-backed guidance on what works. It helps people put evidence-based practices into action for better mental wellbeing, activating positive behavior change.

For sponsoring organizations – such as health plans, employers and community-based public health agencies, CredibleMind captures hard-to-get data to drive stronger planning, faster triage, personalized care navigation, and cost-effective achievement of quality and care outcomes in behavioral health.

“The majority of communities and health plans nationwide have ranked mental health as a top-three priority, yet few have a cost-effective way to fully address these needs, upstream, and at scale,” said Deryk Van Brunt, DrPH, founder and CEO of CredibleMind. “CredibleMind was born out of the recognition that we need to move to a population-based mental health system of care. We’re delighted to have the support of Horizon Mutual Holdings, as well as our existing investors who participated in this round.”

CredibleMind will use funds raised to accelerate growth in both its Health Plan and Public Health businesses. Funding will also facilitate further development of its AI-infused data engine for improving resource curation, consumer activation, care navigation, and for advancing quality and care outcomes.

“CredibleMind has pioneered an accessible, smarter entry point for members seeking mental health and wellbeing support,” said Suzanne Kunis, Chief Executive Officer of NovaWell, Horizon Mutual Holdings’ behavioral health solutions company. “Their work is foundational to building a modern, integrated behavioral health ecosystem, and we’re excited to support their mission of transforming mental health care on a large scale.”

About CredibleMind
Leading health plans, program providers, and over 100 communities across the U.S., rely on CredibleMind to empower member mental health anytime, anywhere. Our evidence-based, AI-infused population digital mental health platform scales screening, prevention, referral, and early intervention. Using rules and resources customized for each setting and tailored for everyone, we create a better front door to behavioral health. For more information, visit us at crediblemind.com

Contact information:
CredibleMind:
Ashley Walker
[email protected] 

SOURCE CredibleMind

WANT YOUR COMPANY’S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

Investments will support new product offerings, US expansion, and development of pathology foundation models.

BERLIN and NEW YORK, Oct. 29, 2024 — Aignostics, a global artificial intelligence (AI) company that turns complex multi-modal pathology data into transformative insights, announced today that it has raised $34 million in Series B financing. This additional funding will be used to build new product offerings for biopharmaceutical clients, fuel growth within the United States (US), and develop leading foundation models for pathology in collaboration with Mayo Clinic. The oversubscribed funding round was led by ATHOS, with investments from Mayo Clinic and growth financing from HTGF, alongside support from existing investors Wellington Partners, Boehringer Ingelheim Venture Fund, CARMA Fund, and VC Fonds Technologie managed by IBB Ventures. In total, Aignostics has now raised over $55 million, reflecting investors’ confidence in its differentiated AI models and clear commercial strategy.

As precision medicine becomes more nuanced and complex, biopharmaceutical companies are increasingly turning to AI to enhance the utility, performance, and scalability of computational pathology analyses for drug development and diagnostics. In parallel, machine learning technologies are rapidly evolving, producing AI models with record accuracy and robustness, opening new avenues for biopharmaceutical research and diagnostics.

“At its core, Aignostics is a world-class machine learning company,” said Julian Zachmann from ATHOS. “The field is advancing so quickly that, in order to succeed, AI companies need to avoid flashy distractions, stay laser focused on the highest-quality science, and relentlessly innovate. Aignostics is doing just that and bringing a level of transparency and rigor to its biopharmaceutical clients that we think is truly unique.”

“We know that digital pathology, paired with the vast capabilities of AI, has immense potential to impact diagnosis and treatment for patients. Mayo Clinic is actively charting the new frontier of predictive and personalized care,” shared Jim Rogers, CEO of Mayo Clinic Digital Pathology.

The new funding will strengthen Aignostics’ offerings for target ID, translational research, and companion diagnostics (CDx), and support several strategic initiatives, including:

• Launch of scaled “plug-and-play” products for a range of indications and tasks, including tumor microenvironment and biomarker profiling.
• Continued expansion into the US with additional headcount and support for US partners.
• Collaborative development of foundation models and biopharma product offerings with Mayo Clinic.

“2024 has been a pivotal year for us that has included a major strategic collaboration with Bayer and the launch of our first foundation model, RudolfV,” said Viktor Matyas, CEO and Co-Founder of Aignostics. “With RudolfV, we’ve gained the ability to quickly develop cost-efficient algorithms that generalize to the real-world. Now with this new round of funding, we’re turning our most popular algorithms into products that will help usher in an era of truly generalizable AI for computational pathology.”

About Aignostics
Aignostics is an artificial intelligence (AI) company that turns complex multimodal pathology data into transformative insights. By combining proprietary access to multimodal clinical data, industry-leading technologies, and rigorous science, Aignostics develops best-in-class products and services for the next generation of precision medicine. Through collaborations with its biopharma partners, Aignostics supports drug discovery, translational research, clinical trials, and CDx development. Established in 2018, Aignostics is a spin-off from Charité Berlin, one of the world’s largest and most esteemed university hospitals. Aignostics is funded by leading investors and has operations in Berlin and New York.

More information at: www.aignostics.com
Follow us on LinkedIn: www.linkedin.com/company/aignostics

About ATHOS
With its heritage in healthcare and life sciences, ATHOS is a single-family office that supports entrepreneurs to positively impact health and well-being. Known to the broader public as the long-term majority investor of BioNTech, ATHOS remains committed to advancing medical innovation and building transformative companies for the future.

About HTGF – High-Tech Gründerfonds
HTGF is one of the leading and most active early-stage investors in Germany and Europe, financing start-ups in the fields of Deep Tech, Industrial Tech, Climate Tech, Digital Tech, Life Sciences and Chemistry. With its experienced investment team, HTGF supports start-ups in all phases of development into international market leaders. HTGF invests in the pre-seed and seed phase and participates significantly in further financing rounds, since 2024 with the HTGF Opportunity growth fund. Across its funds, HTGF has over 2 billion euros under management. Since its inception in 2005, HTGF has financed more than 750 start-ups and successfully sold shares in more than 180 companies. The Federal Ministry for Economic Affairs and Climate Action, KfW Capital and numerous companies are invested in the HTGF seed funds. Investors in the HTGF Opportunity growth fund include the ERP Special Fund and KfW with the resources of the Zukunftsfonds (“Future Fund”).

More information at: www.htgf.de
Follow us on LinkedIn: www.linkedin.com/company/high-tech-gruenderfonds

Contact
Lisa Zheng
[email protected]

SOURCE Aignostics

WANT YOUR COMPANY’S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

MINNEAPOLIS, Oct. 28, 2024 — Alimetry has raised an oversubscribed US $18m A2 financing round to commercialise its wearable gut health monitoring device, capitalizing on increased adoption by a growing cohort of US hospitals. This adoption is driven by Alimetry receiving its fourth FDA clearance, the establishment of a CPT III reimbursement code, and the completion of over 30 clinical studies. Alimetry’s flagship AI powered product delivers accurate analysis and diagnosis of gut disorders that have been proven difficult to solve using conventional diagnostics and testing. The oversubscribed round was led by GD1 (Global from Day One), with participation from the American Gastroenterological Association (AGA) GI Opportunity Fund, Olympus Innovation Ventures, IceHouse Ventures, and follow on from existing investors. 

Nearly one in 10 people suffer from chronic gut symptoms ranging from abdominal pain to chronic indigestion, nausea and vomiting. The current diagnostic journey is slow and poor for patients, causing them to suffer through this period with a reduced quality of life. Alimetry is reducing the cost, time, and complexity of gut health diagnostics by providing rapid, upfront clarity and diagnosis that allows more effective and definitive treatment.

“Alimetry was designed to introduce clarity into a field that has involved lengthy, uncertain diagnostic journeys. It gives clinicians the tools they need to quickly and correctly diagnose patients so that we can move on from trial and error –  and guesswork –  into clarity of care and personalised medicine,” explains Alimetry chief executive Dr. Greg O’Grady, who is also a Professor of Surgery at the University of Auckland.

“Alimery turns months or even years of testing into improved clarity and safer, more accessible, less invasive care. They’ve demonstrated the power of technology to usher in a new era of tech-enabled diagnostics – in this case the undeniable connection of gut health to patient health,” comments Vignesh Kumar, GD1 Co-Managing Partner.

How it works

Like the heart, the gut produces electrical current but these are 100 times weaker than the heart. Alimetry’s highly sensitive wearable device detects these electrical currents from the skin’s surface (called Body Surface Gastric Mapping), similar to an ultra-high resolution electrocardiogram (ECG). Recordings of these signals are taken while patients eat and digest a meal. At the same time, patients log their symptoms into an app.

The device sends the patient’s gastric electrophysiology to the cloud where advanced, AI-powered analysis is performed using smart algorithms based on thousands of diverse and representative test cases used to train and improve benchmarking. The resulting auto-generated Gastric Alimetry Report provides clinicians with objective, data-driven insights to inform their interpretation and aid the diagnosis and personalised treatment of gastric disorders.

“The AGA GI Opportunity Fund is excited to support Alimetry and its breakthrough platform that will improve the patient experience by reducing both the time and cost of diagnosing GI symptoms,” said Michael L. Kochman, MD, AGAF, MASGE, Wilmott Family Professor of Medicine and Surgery, Center for Endoscopic Innovation, Research and Training, Gastroenterology Division, University of Pennsylvania Health System; Fund Manager and Advisor, AGA GI Opportunity Fund.

Making sense of the gut-brain connection 

“Gastric ailments have a myriad of causes – arising from diets, diseases, and the vagus nerve (physiological causes) to things like stress and the gut-brain axis. Having a multimodal platform that assesses all of these things at the same time is a game-changer for clinicians. The Alimetry digital health and wearable platform includes physiology tracking and symptom tracking through gut-brain health questionnaires built into the accompanying app, allowing clinicians to turn a previously confusing picture into a specific diagnosis that paves the way for personalised medicine,” explains Chris Andrews, Chief Medical Officer and Professor of Gastroenterology at the University of Calgary.

Early uptake following FDA approval

The device and platform have been approved for clinical use by the United States Food and Drug Administration to be rolled out to the US market and since controlled market release in 2022. Over 40 hospitals and clinics worldwide have signed on to use the device.

The American Medical Association has established a Category III Current Procedural Terminology (CPT®)  that allows data collection for widespread usage and approval for reimbursement which means the product can be used in hospitals as well as private clinics.

Alimetry also complies with stringent privacy regulations, including HIPAA and GDPR.

“Alimetry is transforming how we approach patients with various gastric disorders. It’s difficult not to get over-excited about this”, states physician Bu’ Hayee, Professor of Gastroenterology at King’s College London.

Journey to commercialisation 

Founded by Dr O’Grady and Dr Armen Gharibans in 2019, Alimetry’s research began at the Auckland Bioengineering Institute. The company’s R&D team is headquartered in New Zealand; while its consumables are manufactured in the US where a newly expanded commercial function has been set up to focus on commercialisation, powered by its raise.

“In addition to commercialising our debut product, our team is also focusing on ‘what’s next’ in terms of using our proprietary tech to keep on pushing the limits of what’s possible in industry. We’ll be introducing new features and new elements of our platform as well as expanding into using Alimetry beyond the gut – such as paediatrics. The technology is also suited for use in other organs such as the colon, ultimately, helping us reach even patients with accurate diagnostics with the potential to radically transform their health,” concludes Dr O’Grady.

(ENDS)

About Alimetry

Alimetry was founded in 2019 with the goal of making gut health accessible to everyone. The company was founded on a background of world-leading science in gastrointestinal diseases. With offices in the United States and New Zealand, Alimetry is dedicated to improving the lives of patients by delivering innovative medical solutions to advance GI diagnostics and enable targeted therapies.

SOURCE Alimetry

WANT YOUR COMPANY’S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

Agency Donates $10,000 to Support Free Speech and Ethical Journalism

NASHVILLE, Tenn., Oct. 28, 2024 — Tiny Mighty Communications, a fast-growing corporate and marketing communications firm, is celebrating five years of year-over-year growth, marking a significant milestone in its journey of serving major industrial and manufacturing brands. Since its founding in 2019, the firm has grown from a small startup to a top agency operating in middle Tennessee, known for its expertise in automotive and transportation, building and construction, and advanced manufacturing and materials.

“We founded Tiny Mighty to help industrial businesses navigate the unique communications challenges of being engineered, specified, regulated and distributed. Five years in, we’re grateful to our clients for trusting us and to our team for building their careers here,” said Paul Oakley, founder and chief executive officer (CEO) of Tiny Mighty Communications. “Nashville’s entrepreneurial energy and dynamic agency scene has fueled our growth. As the city continues to gain global recognition, we’re poised to make an even greater impact with mid-sized and large companies.”

Industry Leadership, Recognition and Awards
Tiny Mighty Communications has made significant strides in critical industries, with strong Fortune 500 client partnerships. Its growth has landed the agency on the Nashville Business Journal’s list of top PR firms for three years consecutively, rising to number six in 2024 based on 2023 results of more than $2 million in top line revenue.

During that time, Tiny Mighty has expanded to 12 professionals and several strategic contract-based collaborators, allowing the firm to address evolving market segments and further embed itself in key client verticals.

The firm’s innovative work across industries and nonprofits has earned nearly 20 Parthenon Awards and recognitions from the Nashville chapter of the Public Relations Society of America (PRSA). Also recently, Tiny Mighty Communications was honored as a double finalist at the Nashville Entrepreneur Center’s NEXT Awards—nominated for Start-up of the Year in the Products and Services category, with Founder Paul Oakley receiving an additional nomination for the prestigious Entrepreneur of the Year award. These accolades recognize both Oakley’s leadership and the firm’s rapid growth.

Aggressive Growth and Future Vision
Tiny Mighty Communications has aggressive ambitions, with a clear vision to become the go-to agency for industrial clients. The firm is exploring plans to expand with brick-and-mortar offices not only in Nashville but also in key regions like the Gulf Coast and Great Lakes. As the agency continues to push boundaries in industrial communications, it remains focused on competing for global clients while also supporting mid-sized companies seeking to differentiate themselves in their markets.

“Continued success requires that we stay deeply curious about our clients’ businesses and the complex value chains they operate in,” said Oakley. “We aim to exceed their expectations while building a team of PR and marketing experts who want to redefine B2B integrated communications.”

To that end, the firm will focus on strengthening its team of seasoned subject matter experts through both organic growth and strategic acquisitions. This includes adding top digital talent and leading content creators, while expanding its capabilities in key growth areas such as corporate and sustainability communications.

Purpose-Driven Giving: Supporting Free Speech and Journalism
To commemorate its fifth anniversary, Tiny Mighty Communications is donating $10,000 to non-profit organizations that protect free speech, support the journalism profession and ensure that diverse and underrepresented voices continue to be heard. Locally, donations are being directed to Nashville Banner, Nashville Public Television, Nashville Scene, Nashville Public Radio, and Tennessee Tribune. Nationally, Tiny Mighty is investing in the Poynter Institute and Reporters Committee for Freedom of the Press.

To learn more about Tiny Mighty Communications, the agency’s work and team, click here.

About Tiny Mighty Communications
Tiny Mighty Communications is a corporate and marketing communications agency that helps industrial and manufacturing brands grow by engaging those who matter most. Specializing in sectors like automotive, building products, construction and advanced materials, the firm focuses on businesses that are engineered, regulated, specified and distributed. Headquartered in Nashville, Tiny Mighty Communications delivers data-driven strategies in corporate reputation, employee engagement, media relations, digital marketing, sustainability, crisis management and more. Trusted by brands big and small, the agency is committed to challenging the status quo, taking calculated risks and setting new standards for success. More information is online at www.tinymightyco.com.

Media Contact: Kamryn Heath / [email protected] / (704) 804-0076

SOURCE Tiny Mighty Communications

WANT YOUR COMPANY’S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

LONDON, Oct. 28, 2024 — Libraro, a community-driven platform connecting writers, readers, and publishers, is thrilled to announce the completion of the first stage in its seed funding round, led by Ayre Ventures. The investment will accelerate Libraro’s mission to empower authors and readers, creating a space where great stories find their way to engaged audiences. Libraro’s seed round remains open for select additional investors to participate.

Arsim Shillova, Co-Founder and CEO of Libraro, said: “This funding gives us the momentum to expand our platform and create a thriving environment where emerging authors are discovered, and readers engage with original, meaningful stories. We’re excited to offer a space that complements traditional publishing, unlocking new opportunities for the entire literary community.”

Libraro’s platform harnesses scalable blockchain technology to protect authorship, prevent copyright infringement, and enhance transparency in ownership and distribution rights. With its Web3 loyalty program, Libraro creates deeper engagement, building trust among readers, authors, and publishers alike.

Ayre Ventures founder Calvin Ayre said: “Mankind’s history is the history of the written word, without which progress would have been infinitely slower. Ayre Ventures is thrilled to support Libraro and its goal of connecting authors, readers and publishers via a secure and stable enterprise blockchain-enabled platform.”

About Libraro

At Libraro, every good story deserves a platform. We’re a community-driven platform where writers, readers, and publishers come together to discover, share, and celebrate great stories. Our mission is to give every voice the opportunity to be heard and ensure that meaningful stories reach the readers who’ll appreciate them.

www.libraro.io

About Ayre Ventures

Ayre Ventures, founded by renowned venture capitalist and philanthropist Calvin Ayre, provides funding to scalable, high-growth businesses that use frontier technologies like AI, IPv6 and Enterprise Blockchain—including BSV, the world’s only unboundedly scaling public proof-of-work enterprise blockchain. The Group targets investment in innovative ideas and ambitious projects that are “positively disruptive,” supporting their expansion with the Group’s extensive network and industry partners.

https://ayre.group/investments

SOURCE Ayre Ventures

WANT YOUR COMPANY’S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

XP Health also adds former Oracle executive and Bessemer Venture Partners leader Jeff Epstein to its board of directors

SAN CARLOS, Calif., Oct. 28, 2024 — XP Health, a company dedicated to modernizing vision care with a digital-first vision, announced two key partnerships with leading platforms that access many employers and benefits plans: Employee Navigator, one of the nation’s leading benefits administration platforms, and Bennie, an employee benefits platform that provides an easy way to access and understand benefits.

These exciting new partnerships will expand XP Health’s reach to more potential members and make the vision care experience even more seamless for both employees and human resources managers.

The partnership with Employee Navigator will allow XP Health to offer six different vision programs with rates ready to go for customers – with no individual quoting required. XP Health’s pre-packaged vision programs will be available in Employee Navigator’s Marketplace, both at an employer-sponsored and employee voluntary level, eliminating the complexity and wait times for quoting and empowering brokers to provide top-tier vision care immediately and seamlessly without the usual back-and-forth. 

“We are super excited that XP Health is integrated on Employee Navigator!” exclaimed Matt Mink, managing principal, OneDigital a power user of Employee Navigator. “This will enable us to seamlessly bring XP Health to all of our clients who are looking for better vision care.”

Like Employee Navigator, Bennie’s platform brings XP Health access to additional members and additional seamlessness to the process. Bennie customers will be able to access XP Health via Bennie’s Employer Marketplace, where administrators can browse and select benefit options to add to their organization’s offerings.

Founded in 2019, Bennie’s all-in-one platform brings competitive plans to their members for an easy, convenient benefits experience. The Bennie Marketplace offers members discounted rates on a wide range of insurances, family planning tools, and health and wellness solutions. The Bennie App makes it easy for employees to fully benefit from their benefits and access plan information, find in-network doctors, and chat with a healthcare concierge about questions regarding claims, coverage, and more.

“Like XP Health, we are here because the benefits industry needs to change,” said Ronelle Lichman, director of partnerships, Bennie. “At Bennie, we understand that companies are eager to find simple, modern, and useful solutions for vision care that seamlessly integrate into one platform for all of their benefits and HR needs.”

“Both Employee Navigator and Bennie offer leading platforms that will mesh with our offerings. The vision programs will be branded as XP Health, with Employee Navigator as the conduit to brokers and their clients,” added Ryan VanOverbeke, chief commercial officer, XP Health. “Our pre-packaged vision programs are available instantly in Bennie’s Employer Marketplace and live in the coming months in Employee Navigator’s Marketplace, eliminating the complexity and wait times for quoting, empowering brokers to provide top-tier care offerings immediately and seamlessly without the usual back-and-forth.

These impactful partnerships come on the heels of XP Health’s new $33.2 million Series B infusion round of funding led by global fintech VC firm QED Investors with other prominent investors including Canvas Ventures, Semper Virens, American Family Ventures, HC9 Ventures, Valor Capital Group, and Manchester Story. The company offers vision care programs that help reduce employee expenses, while providing refreshingly pleasant consumer experiences. Its vision programs cover more than 250,000 people and have seen rapid growth in the last two years since launching its platform, expanding from 30 to over 3000 business customers, including DocuSign, Navistar, Chegg, Sequoia Consulting, and strategic partners like The Guardian Life Insurance Company of America.

Continuing on its growth trajectory, XP Health has also welcomed to its board of directors noted Silicon Valley executive and investor Jeff Epstein, former executive vice president and CFO of Oracle, and operating partner at Bessemer Venture Partners. Jeff is a board member of several companies including Okta ($12 billion market cap), Twilio ($11 billion market cap) and the non-profit Kaiser Permanente ($100 billion revenue).

“Healthcare is a challenging and exciting sector, and XP Health’s vision care programs are changing the way vision care is offered with new depth of choice for patients and new opportunities for employers to look out for their employees,” said Jeff Epstein, operating partner at Bessemer Venture Partners and XP Health board member. “I look forward to bringing my experience with technology and healthcare to support XP Health’s continued rapid growth and success.”

About XP Health
XP Health democratizes access to high-quality, delightful experiences in vision care that doubles coverage and reduces costs. It is a digital-first vision platform focused on eye exams and eyewear that uses customer-centric design and technology to create a better member experience and improve access. XP Health was founded to combat the often confusing, expensive, and frustrating experiences common with vision care. XP Health was named to Fast Company’s 2021 list of “The World’s Most Innovative Companies,” and over the past couple of years has expanded from 30 to 3000+ customers, including DocuSign, Navistar, Chegg, Sequoia Consulting, and strategic partner Guardian Life Insurance. To learn more visit xphealth.co.

About Employee Navigator
Employee Navigator is a rapidly growing benefits and HR software company integrated with over 400+ of the nation’s leading insurance carriers, payroll companies, and TPA’s. Its platform delivers brokers and employers a connected digital experience, streamlining the management of everything from online enrollment and onboarding to ACA reporting, time off tracking, and more. The company currently works with more than 5,000 brokers, providing benefits administration and HR products to over 175,000 companies and 14+ million employees and dependents. For more information, visit www.employeenavigator.com

About Bennie
Bennie provides a modern, cost-effective approach to employee benefits with a user-friendly app and world-class brokerage services. The Bennie App is a go-to resource for employees to easily find and understand benefits information. From viewing ID cards to finding in-network providers to connecting with Ask Bennie (a dedicated healthcare concierge service within the app), employees have the benefits information and tools they need. To learn more, visit Bennie.com or contact us today.

Media Contacts
Ivy Cohen
Ivy Cohen Corporate Communications
(212) 399-0026
[email protected] 

Chris Flores
Bennie Media
(866) 319-7358
[email protected]

Employee Navigator
(301) 583-5180
[email protected]

SOURCE XP Health

WANT YOUR COMPANY’S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

Investment will accelerate expansion of new features that are essential to the value-added
services and benefits that Wildfire’s clients extend to their customers

SAN DIEGO , Oct. 28, 2024 — Wildfire Systems Inc., an innovative financial technology platform that powers loyalty and reward programs, shopping companions, and content monetization, today announced that it has secured $16 million in Series B funding. The round is co-led by Intuit Ventures and  Mucker Capital. In addition, new investors Cohen Circle, Samsung Next, Evolution VC, and Gaingels, plus existing investors TTV Capital, QED Investors, B Capital, DLA Piper, Moonshots Capital, and Citi Ventures participated in the round.

Wildfire will leverage the new capital for continued innovation and deployment of its platform that enables financial services organizations and technology companies including RBC, Visa, Citi, Acorns, and Microsoft, to provide rewarding online shopping experiences to consumers worldwide. Many of Wildfire’s clients are looking for solutions to a similar set of challenges, including building new revenue streams, retaining customers, and staying top-of-mind and top-of-wallet; Wildfire helps clients achieve these goals with loyalty as a profit center. The Series B brings Wildfire’s total funding raised to date to $36 million.

“Wildfire has achieved significant growth in recent years, continually expanding both our product offerings and geographic reach. Our mission is to provide consumers with personalized, meaningful benefits throughout their entire online shopping journey, while empowering our partners to deliver distinctive, value-added services to their users,” said Jordan Glazier, Wildfire’s founder and CEO. “We’re thrilled to welcome Intuit Ventures and other new investors on board, and I’m deeply appreciative of the enthusiastic support from our existing investors.”

As part of providing white label loyalty solutions for clients, Wildfire’s platform also creates an efficient channel for advertisers to achieve high return on ad spend. Wildfire works with leading performance marketing platforms such as CJ, Impact.com, and Rakuten Advertising to drive incremental sales for more than 50,000 merchant programs in 50 countries. This enables advertisers to reach engaged audiences who are actively shopping, with the added impact of benefits offered through their trusted brands and financial institutions.

“Consumers are facing high prices and inflation while businesses struggle to capture consumer attention in an increasingly crowded online landscape,” said Selina Troesch, Principal, Intuit Ventures. “Wildfire is an ideal fit for Intuit’s goal of helping consumers and businesses overcome their most important financial challenges, including saving money and driving loyalty. Wildfire and its partners offer benefits that are relevant to our approximately 100 million consumer and business customers.”

“Wildfire has done an outstanding job executing and evolving its business since we first invested in 2017. Their white label platform has extended to an impressive product mix and has become an essential part of the consumer value proposition of several of the world’s leading companies,” said William Hsu, Co-founder & Partner, Mucker Capital.

For more information on Wildfire Systems and the company’s rewards platform please visit: https://www.wildfire-corp.com. 

About Wildfire Systems, Inc.

Founded in 2017, San Diego-based Wildfire’s enterprise platform powers white-label shopping rewards and loyalty programs for financial services organizations and technology companies, allowing them to deploy revenue-generating, value-added services for their customers. The platform provides a shopping companion designed to reward consumers with cashback, coupons, and other benefits at every stage of their shopping journey. Wildfire drives incremental sales for over 50,000 merchant programs in more than 50 countries. Wildfire’s AI platform, RevenueEngine, helps content creators monetize product and brand mentions within generated content. Wildfire has been recognized in 2023 & 2024 within the top 100 fastest growing companies in the Inc. 5000, most recently celebrating 3,783% three-year growth. For more information, visit wildfire-corp.com.

SOURCE Wildfire Systems

WANT YOUR COMPANY’S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

PayToMe.co Simplifies Global Payments, Cross-Border Transactions, and Drives Financial Inclusion

PALO ALTO, Calif., Oct. 28, 2024 — PayToMe.co, an AI-driven fintech platform simplifying global payments and cross-border transactions for SMBs, proudly announces the successful completion of its Seed Round, with investments from Startupbootcamp and ACH Australia Investments Pty Ltd. This milestone accelerates PayToMe’s mission to build the first-ever fintech marketplace, empowering SMBs to access a comprehensive suite of financial services in one platform—similar to Amazon’s transformation of e-commerce. PayToMe is also deeply committed to promoting financial inclusion, ensuring that even underserved businesses can access critical financial tools.

Completion of Seed Round

Since 2010, Startupbootcamp has operated over 150 accelerators in more than 20 countries, helping over 1,600 startups reach their full potential. On average, startups in the program experience a 2.5x increase in valuation and raise approximately €1.5 million within six to twelve months of completing the accelerator.

“PayToMe.co is honored to receive seed investment and join the Startupbootcamp Cohort, an honor reserved for the top 1% startups globally,” said Mike Ulker, CEO and Founder of PayToMe.co. “With the support of Startupbootcamp, the world’s top accelerator, we are significantly accelerating our growth.”

Value Proposition

Globally, over 400 million SMBs lose $48 billion annually due to fraud, invoicing errors, payment delays, representing a $150 billion opportunity in the fintech market.

PayToMe.co solves these inefficiencies with an AI-powered platform for global payments, customizable invoicing, and cross-border transactions. Through leading partners like Plaid, Stripe, and US Bank, we connect 12,000 financial institutions and 7,000 applications globally, creating an inclusive, scalable, and efficient financial ecosystem. Backed by strategic partners and shareholders including Startupbootcamp, ACH Australia Investments Pty Ltd., and AppTech Payments Corp. (Nasdaq: APCX), PayToMe.co is well positioned to revolutionize fintech on a global scale, offering a compelling opportunity for investors committed to global financial inclusion.

Preparing for Series A Funding

Following the successful seed round, PayToMe.co is now preparing for its Series A funding. The proceeds from the funding will be used to scale its platform, expand its go-to-market strategy, and drive cross-border user acquisition. With a proven track record, global partnerships, and cutting-edge technology, PayToMe.co is ready to accelerate its growth and make a lasting impact on the financial services sector.

About PayToMe.co:

Based in Silicon Valley, PayToMe.co is a fintech marketplace specializing in AI-driven payment solutions, cross-border financial transactions, and customizable digital invoicing for over 100 countries. With connections to 12,000 financial institutions and 7,000 applications through technology and strategic partnerships, including Stripe, Plaid, US Bank, Startupbootcamp, and AppTech Payments Corp. (Nasdaq: APCX), PayToMe.co is at the forefront of innovation in the financial services industry. Its suite of services, including Payment-as-a-Service (PaaS), Banking-as-a-Service (BaaS), and Software-as-a-Service (SaaS), empowers businesses to optimize financial processes, enhance cash flow, reduce fraud while contributing to a sustainable and socially responsible financial ecosystem. PayToMe has been honored with eight American and International business awards for Technology Excellence and Social Impact. For more information, visit www.paytome.co.

Media Contact:
Mike Ulker
(650) 963 4969

Email: [email protected]

SOURCE PayToMe.co

WANT YOUR COMPANY’S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

Backed by IBF, Merz, and Laborie, Vensica to Advance Needle-Free Delivery of Botulinum Toxin A (Xeomin^®) for Minimally Invasive Treatment

BROOKLYN, N.Y., Oct. 28, 2024 — Vensica Medical (“Vensica”), a pioneering urology therapeutics company, today announced the successful closing of an $11 million funding round. The investment will fund the company’s upcoming Phase 2 clinical trials across the United States and Europe for its revolutionary treatment of overactive bladder (OAB) using botulinum toxin A (Xeomin^®) delivered through a proprietary, needle-free device.

The investment round was led by Israel Biotech Fund (IBF), alongside key strategic partners, Merz, a global player in neurotoxins, and Laborie, a prominent urology medical device company. This funding will enable Vensica to continue its mission of providing a minimally invasive, simple, and effective solution for people with overactive bladder (“OAB”).

Vensica’s unique technology leverages a needle-free drug delivery system, that administers Xeomin^® directly to the bladder wall. This approach is expected to offer patients a less invasive, more comfortable treatment option compared to traditional injections, potentially transforming the standard of care for OAB. Vensica’s needle-free drug delivery system aims to be a urology treatment platform for the treatment of additional bladder indications.

“We are thrilled to have the support of leading investors and partners who share our vision of transforming overactive bladder treatment,” remarked Avner Geva, CEO of Vensica. “This funding will allow us to push forward with Phase 2 trials and move one step closer to bringing this innovative therapy to the patients who need it.”

As part of its strategic partnership with Merz, Vensica has secured exclusive rights to Xeomin^® in needle-less therapeutic application in several urologic indications and will benefit from Merz’s clinical development support. This collaboration marks a significant step forward in the company’s goal of delivering next-generation urology treatments.

For more information on Vensica and its upcoming clinical trials, visit https://vensica.com/.

About Vensica Medical

Vensica Medical is a biotechnology company focused on developing novel therapies for urological conditions. The company’s leading product is a needle-free delivery system for Xeomin^® (botulinum toxin A) aimed at treating overactive bladder in a minimally invasive manner. Vensica was established in the incubator program of The Trendlines Group (SGX: 42T) (OTCQX: TRNLY), and The Israel Innovation Authority.

Contact: 
Avner Geva, Chief Executive Officer
[email protected]

Photo: https://mma.prnewswire.com/media/2541677/CTO_Co_Founder_Vensica_Medical.jpg

SOURCE Vensica Medical

WANT YOUR COMPANY’S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In